XB
XTL Biopharmaceuticals Ltd ADR
🇩🇪XSTU.H2K2GermanyHealthcare
€0.46EURup +0.01 (+2.22%)OpenEnd of day9:13 AM
Price€0.46+0.01 (+2.22%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Stuttgart Stock Exchange . XSTU
- Type
- Stock
- ISIN
- US98386D3070
- CUSIP
- Not reported
Company
- Employees
- 4
- Headquarters
- Herzliya, United States
- Website
- https://www.xtlbio.com
- CEO
- Mr. Noam Band
Market
- Shares outstanding
- 0
- Market cap
- Not reported
Highlights
- Market cap
- Not reported
- EPS LTM
- -$4.01
- P/E LTM
- -0.30
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $740K+100%up year on year
- Net income
- -$1.77M-1,774.12%down year on year
- Gross margin
- -5.41%
- Free cash flow
- Not reported
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.